We are pleased to announce that Celeid Therapeutics has been selected as a finalist for the “TCI-VENTURE AWARD 2024 [Start-up Division].
Nobuyuki Arakawa, CEO of our company, will be speaking at the pitch event for the “TCI-VENTURE AWARD 2024 Final” to be held on December 6, 2024, and will be giving a talk on the development of cell and gene therapy using ex vivo expansion technology for hematopoietic stem cells.
Date and time : Friday, December 6, 2024, 13:30-
Venue: Tsukuba Research Support Center, Training Room A (2-1-6 Sengen, Tsukuba City)
Online: Webinar via Zoom
Capacity
Venue: 40 people
Online: 500 people
Participation fee
Free
Application form
Venue : https://www.tsukuba-tci.co.jp/entryform/241206startup
Online : https://us06web.zoom.us/webinar/register/WN_tNUBvN9iQlihPwuDb_FShA#/registration
Program (tentative)
13:30 Opening
13:50 Start of pitches
16:00 - Judging begins (Networking event for general participants)
16:50 - Award ceremony
17:30 - Networking event